Compare CCM & SNES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CCM | SNES |
|---|---|---|
| Founded | 1997 | 2004 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Medical/Nursing Services | Agricultural Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.9M | 12.1M |
| IPO Year | 2009 | 2016 |
| Metric | CCM | SNES |
|---|---|---|
| Price | $3.91 | $1.61 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 874.0 | ★ 49.4K |
| Earning Date | 04-24-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 77.99 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $600,000.00 |
| Revenue This Year | N/A | $29.00 |
| Revenue Next Year | N/A | $95.04 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 132.56 |
| 52 Week Low | $3.18 | $1.32 |
| 52 Week High | $10.77 | $5.99 |
| Indicator | CCM | SNES |
|---|---|---|
| Relative Strength Index (RSI) | 54.16 | 38.67 |
| Support Level | $3.58 | N/A |
| Resistance Level | $4.12 | $2.51 |
| Average True Range (ATR) | 0.11 | 0.12 |
| MACD | 0.04 | -0.02 |
| Stochastic Oscillator | 55.32 | 19.96 |
Concord Medical Services Holdings Ltd operates radiotherapy and diagnostic imaging centers in China. The company is involved in the leasing of radiotherapy and diagnostic imaging equipment, provision of management services to hospitals, medicine sales, and provision of premium cancer and proton treatment services. The company has two operating segments, including network and hospital. Its network includes radiotherapy centers, diagnostic imaging centers, and centers providing other treatment and diagnostic services.
SenesTech Inc is a United States-based biotech platform and research company engaged in developing technology for managing animal pest populations through fertility control. The company provides its solutions to the animal market, commercial markets, and food markets. It currently has two product lines of fertility control products: ContraPest and Evolve.